Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IPO round-up: ReWalk walks away with less than expected; Mevion targets $69m

This article was originally published in Clinica

Executive Summary

ReWalk Robotics has priced its initial public offering and started trading on the Nasdaq – but the total $36m raised fell short of its previous target. The firm initially said it wanted to pull in $57.5m; then reduced this target to around $51m. However, it is not all bad news: the company’s shares, which trade under the ticker symbol RWLK, were up 113% at $25.60 on 12 September, its first day of trading.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT101920

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel